Conclusion: MWA and PSE were effective in treatment of hypersplenism in patients with liver cirrhosis, while percutaneous MWA has less serious complications than PSE. Asar et al., Afro-Egypt J Infect Endem Dis 2019; 9(3):230-240 https://aeji.journals.ekb.eg/
Background and study aim: In patients suffering from portal hypertension as result of liver cirrhosis, hypersplenism was ranged from 11 to 55%. The aim of our work was to compare between percutaneous microwave ablation (MWA) and partial splenic artery embolization (PSE) in the management of hypersplenism in patients with liver cirrhosis as regard efficacy and safety.
Patients and Methods:
Sixty patients with liver cirrhosis complicated with splenomegaly and hypersplenism were divided randomly into three groups; Group (1): Twenty patients were underwent one session of MW ablation of splenic parenchyma with target ablation volume about 20%, Group (2): Twenty patients were underwent two sessions of MW ablation of splenic parenchyma with 1 week interval with target ablation up to 40%, Group (3): Twenty patients were underwent PSE.
Results: There was an improvement in the hemoglobin, platelet and leucocyte levels in three groups, which was 9.47± 2.14 gm/dl, 42.75 ± 15.4 x10 3 / mm 3 and 2.6±0.5 x10 3 /mm 3 before the procedure respectively and become 9.95 ± 2.29 gm/dl, 313.5±99.6 x10 3 /mm 3 and 6.88± 1.89 x10 3 /mm 3 after one month as regard PSE group. As regard one session of MWA was 9.73±2.02 gm/dl, 45.57±11.2 x10 3 /mm 3 and 2.8±0.85 x10 3 /mm 3 and become 11.83±0.74 gm/dl, 152±26.43 x10 3 /mm 3 and 5.85±1.01 x10 3 /mm 3 after one month. As regard two sessions of MWA group; was 9.2±2.15 gm/dl, 40.6± 11.5 x10 3 /mm 3 and 2.4±0.55 x10 3 /mm 3 and become 12.74±1.2 gm/dl, 183.4± 26.43 x10 3 /mm 3 and 6.29±1.17 x10 3 /mm 3 after one month. PSE was significantly more effective in the elevation of platelets and leucocytes than other two groups (p=0.00), and two sessions of MWA more than one session of MWA. The two sessions MWA group was significantly higher than other two groups while one session of MWA group was more than PSE group in the elevation of hemoglobin (p=0.00). No mortality occurred in the three groups, but PSE was associated with more serious complications than the other two groups.
INTRODUCTION
Hypersplenism is a syndrome in which there is enlargement of the spleen, associated with a decrease in one or more of the cell lines of the peripheral blood with normocellular or hypercellular bone marrow and this deficit is corrected by splenectomy.
However, there are cases such as essential thrombocytopenic purpura where the spleen may be not enlarged
When the underlying disease causing hypersplenism cannot be determined, it is called primary hypersplenism [2].
When the underlying cause of hypersplenism can be identified, it is called secondary hypersplenism. The most common cause of secondary hypersplenism is the chronic liver disease [3] .
The cause of the liver disease influences the frequency of splenomegaly. Patients with idiopathic portal hypertension typically have large spleens, and it has been reported that patients with non-alcoholic cirrhosis tend to have larger spleens than patients with alcoholic cirrhosis [4] .
Hypersplenism associated with retention of a large number of leukocytes, erythrocytes and platelets in the spleen. The number of retained blood cells can be 5.5-20 times higher than the normal level, thus facilitating capture, phagocytosis or destruction of blood cells by phagocytes resulting in peripheral cytopenia [5] .
Due to the low platelets count , patients develop bleeding manifestations of skin and mucous membranes and reduction in red blood cells causing anemia which in turn leads to lack of oxygen and disturbance of daily activities as well as neutropenia lead to increased vulnerability for the infections which may be very severe and fatal. So hypersplenism with recurrent spontaneous bleeding, frequent blood transfusion or severe recurrent infection is a clinical indication for therapeutic intervention [6].
However, this blood cell destruction can be eliminated by splenectomy, but the incidence of severe complications after splenectomy is depending on whether laparoscopic or open splenectomy is achieved [7] .
In 1973, The first splenic parenchymal embolization was achieved by Maddison [8] .
However, PSE was effective but associated with many adverse events, like fever, vomiting, abdominal pain, splenic rupture, splenic abscess, pneumonia, deterioration of ascites, pleural effusion and hematemesis [9] .
Minimally invasive procedures like thermal ablation methods using different energy sources, like microwave (MW), radiofrequency (RF), or laser, were developed for the elimination of local tumor tissue within solid organs [10].
Either percutaneous or laparoscopic microwave ablation is safe approach for the management of hypersplenism as a consequence of cirrhosis of liver [11] .
PATIENTS AND METHODS
In this prospective randomized study sixty patients with post-HCV liver cirrhosis complicated with splenomegaly and hypersplenism attended to Egyptian National Hepatology Institute in Cairo in the period from January 2017 to March 2019 with clinically severe hypersplenism. They were randomly allocated into three groups: Group (1) Twenty patients were treated with one session of microwave ablation of parenchyma of spleen with target ablation volume about 20%, Group (2): Twenty patients were treated with two sessions of microwave ablation of parenchyma of spleen with one-week interval between two sessions with target ablation about 40% and Group (3) Twenty patients were treated with Partial splenic embolization.
All patients were subjected to full history taking, thorough clinical examination and detailed investigations (bilirubin level, serum albumin, renal functions, INR and full blood count). Diagnosis was based on full blood count and confirmed with bone marrow examination and diagnosis of portal hypertension and liver cirrhosis was through clinical examination and laboratory and radiological investigations.
Patients with hypocellular bone marrow, significant cardiac disease, renal impairment, malignant disease, child class C, those with a known allergy to contrast medium and other causes of cytopenia, which may include autoimmune destruction; deficiencies of iron, vitamin B12, or folate; were excluded from the study.
Procedure for splenic microwave ablation: Administration of propofol by anesthetist in operating theatre under monitoring. abdominal wall sterilization, then the microwave needle (AMICA™ -MW Ablation System) was inserted in the splenic parenchyma under ultrasound guidance beyond large vessels and surrounding organs by expert hepatologist.ECO-100C microwave treatment system Nanjing ECO Microwave System Engineering Co., Ltd. Italy. With the MW emitting 80 Watt for 10 minutes was used in the ablation in one session to achieve volume ablation about 20% as done by Assal et al. [12] . When ablation was completed needle track ablation was achieved to avoid post procedural bleeding.
Procedure for partial splenic embolization: through femoral artery approach splenic artery catheterization using the introducer sheath, dilator and guide wire was done according to Asar by expert interventional radiologist. Then the embolizing agent (Embosphere) mixed with lipiodol was injected through special catheters in small increments, the injection of one or two of the polar arteries (according to their size) was sufficient to embolize at least 40-60% of the splenic parenchyma after the embolization was complete, splenic angiography was done to confirm a reduction of approximately 40-60% of the splenic blood flow.
All patients stayed in hospital after procedure under follow up. Supported care included fluid intake, prophylaxis with IV Cefotaxime 1 gm before procedure and continued every 12 hours for five days and Paracetamol 500mg three times daily for 1 week. All patients in three groups were followed up after discharge at 1 week, 1month, and 3 months.
Ethical approved:
Our work was approved by the research ethical committee of Benha faculty of medicine. All included patients were informed about the idea of the study and gave a written consent to participate in the study.
Statistical analysis:
Patient data were statistically analyzed using SPSS. Qualitative data were expressed as number and percentage. Quantitative data were expressed as mean ± standard deviation (SD). The following tests were used to test differences for significance; Difference and association of qualitative variable by Chi square test (X 2 ). Differences between quantitative independent multiple by ANOVA or Kruskal Wallis, paired by paired t or Sign. And post hoc analysis was used to know what specific pairs of group means show differences and what pairs do not. P value was set at <0.05 for significant results & <0.001 for high significant results.
RESULTS
This prospective randomized study was conducted on 60 patients with hypersplenism secondary to cirrhosis, they were 33 (55%) males and 27 (45%) females. One session MWA group: composed of 10 males (50%) and 10 Females (50%). Two sessions MWA group: composed of 10 males (50%) and 10 Females (50%). PSE group: composed of 13 males (65%) and 7 Females (35%). No significant statistical difference was detected between the three groups as regarding gender distribution (p=0.5) ( Table 1) .
The age was distributed as 41.9±10.33 years in PSE group, 42.05±7.87 years in one session MWA and 46.7±9.12 years in two sessions MWA group with no statistically significant difference between them (p=0.17) (Table1).
Splenic size before the intervention was distributed as 20.5±2.07 cm in PSE group, 20.2±1.67cm in one session MWA and 20.4±1.21cm in two sessions MWA group with no statistically significant difference among the studied groups (p=0.17) ( Table 1) .
The laboratory finding before the intervention including, hemoglobin level, leucocytic and platelets counts, INR, bilirubin level, albumin and creatinine level show no statistically significant difference among the three groups ( Table 2 ).
The laboratory findings after the interventions at different intervals show: Hemoglobin showed significant difference among groups start from the first month (9.95±2.29 gm/dl for PSE, 11.83± 0.74 gm/dl for one session MWA and 12.74±1.2 gm/dl for two session MWA) (p=0.01) and continue after 3 months (p=0.002) as two sessions MWA group (12.35±1.29 gm/dl) significantly higher than other two groups and one session MWA group significantly higher than PSE group (Table 3 & Table 4 ). Leucocyte count; show significant difference among groups start from the first week (7.35±1.1 x10 3 /mm 3 for PSE, 4.73± 1.07 x10 3 /mm 3 for one session MWA and 5.05± 1.09 x10 3 /mm 3 for two session MWA) (p=0.003) as PSE group significantly higher than other groups then from first month two sessions MWA group become significantly higher than one session MWA group (Table 3 & Table 5 ). Platelets count; show significant difference from1week till the end as PSE group significantly higher than other two groups (p=0.00) and two sessions group more than one session significantly from first month (252.75±60.69 x10 3 /mm 3 for PSE, 126.95±27.43 x10 3 /mm 3 for one session MWA and 155.95±26.43 x10 3 /mm 3 for two session MWA after three months) ( Table 3 & Table 6 ).
Albumin, bilirubin and INR; show that from first week till the end albumin was significantly lower in PSE group than other two groups but bilirubin was significantly higher in PSE group from one week tell the end (p=0.00) and INR at third month PSE significantly higher than other groups (p=0.019) ( Table 3 ). Creatinine; shows no significant difference among groups after the intervention (Table 3) .
There is no significance difference among the three studied groups in ascites state before the intervention (p=0.7) and PSE group significantly associated with deterioration of the ascites state after 3 months from the intervention (p=0.002) ( Table 7) .
PSE group significantly associated with deterioration in child Turcotte Pugh score (p=0.00) while no change after the intervention in other two groups ( Table 8 ).
The post-intervention complications; revealed that one patient suffered from severe left upper abdominal pain after one session of microwave.
While two patients suffered from severe left upper abdominal pain and two patients developed a small amount of pleural effusion after two sessions of microwave. In PSE group six patients developed partial portal vein thrombosis due to rapid rise of platelets level after the intervention which was managed by anticoagulant, three patients developed pleural effusion, two patients developed hematemesis which related to PSE because we excluded patients with active esophageal varices from our study, two patients developed paralytic ileus and nine patients suffered from left upper abdominal pain so PSE group associated with more serious complications and there were no patients had developed splenic abscess or sepsis after the intervention (Table 9 ). There is significant difference among groups start from first month and continue after 3 months as two sessions group significantly higher than other two groups and one session group significantly higher than PSE group.
(HB: hemoglobin, PSE: partial splenic embolization, MWA: microwave ablation). PSE group significantly higher than other two groups from one week till the end and two sessions group more than one session significantly from 1st month. (PSE: partial splenic embolization, MWA: microwave ablation) 
DISCUSSION
This prospective randomized study was conducted on 60 patients with hypersplenism due to liver cirrhosis.
In the present study, hemoglobin more increased in microwave ablation groups than PSE group and in the two sessions of microwave than one session. This is finding in accordance with Assal et al. [12] , who found significant increase in hemoglobin levels in microwave group compared to PSE group after 3 months of follow up.
The present study showed that, Total leucocyte count and platelets starts to increased significantly from the 1 st week in the PSE and in the two sessions of microwave than one session. This is in accordance with Assal et al. , which can explain the significantly greater degree of increase of leukocytes after PSE than after MWA in our study due to large splenic tissue infarction.
The present study showed that there was significant deterioration in serum albumin and significant increase in bilirubin, INR, amount of ascites and child score after treatment in PSE than other both groups. This is in accordance with Assal et al. , found that only albumin increased but not significantly after microwave, however the other parameters showed no significant change.
In our study no deterioration in kidney functions after procedures due to good preparation before intervention and good hydration after intervention. This is in accordance with Liang et al. [11] , who found that there were no significant changes in renal function. On the other hand, Assal et al.
[12], found increased serum creatinine in partial splenic artery embolization group.
In our study, complications like pleural effusion, severe pain occurred more in PSE and the two sessions of microwave than one session. This is in agreement with Jiang et al. [18] , who found less complication in microwave groups than PSE group and increased complications with the increased ablated areas with microwave ablation. Also, this was in agreement to other studies done by Cai , reported two deaths due to abscess formation and septic shock.
However, both procedures have same therapeutic principles, but MWA was safer than PSE as the latter caused more deterioration of liver functions, worsen degree of ascites, and deterioration of Child score. So, serious adverse events after PSE will make us to prefer MWA techniques to increase the efficacy without losing the safety and two sessions of MWA than one session of MWA.
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